Market Overview

Morning Market Movers

Related BIOL
Former Biolase CEO Announces Resignation From Biolase Board
Former CEO of Biolase Sends Letter To Correct Wrongful Allegations

Sarepta Therapeutics (NASDAQ: SRPT) shares advanced 100.20% to $30.01 at 9:45 am. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients.

BIOLASE (NASDAQ: BIOL) climbed 22.29% to $2.03. BIOLASE has received clearance from the FDA and Conformité Européene Mark approval for its EPIC 10™ diode soft tissue laser.

Ocwen Financial (NYSE: OCN) surged 15.40% to $33.42. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC.

BioLineRx Ltd (NASDAQ: BLRX) surged 14.84% to $2.9972. BioLineRx shares have dropped 23.91% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (BLRX + BIOL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters